MINNEAPOLIS, MN--(Marketwire - August 22, 2011) -
| Highlighted Links |
http://www.biodrainmedical.com |
http://www.cfsg1.com |
Addressing an audience of more than 70 investors on August 18, Mr. Shuler included a newly updated activity report describing the rapidly expanding sales opportunities for BioDrain's unique, patented, FDA approved Streamway System. The report, which was included as a slide in the Company's investor presentation and included below within this release, identifies near-term opportunities from hospitals across the nation with sales potential of over $3 million and long-term opportunities representing sales potential of over $7 million. These figures derive from potential orders for Streamway System units recently identified by our newly expanded sales rep team and the expected recurring revenues from consumables that accrue to each unit. (Hospitals are identified here according to location only.)
"I was excited to present our latest developments in commercializing BioDrain's Streamway System to NIBA's audience of investment banking, corporate finance and investment brokerage firms," declared Mr. Shuler. "Our newly expanded sales rep force is aggressively increasing our ability to demonstrate Streamway's continuous, automated and cost effective process to an expanding number of hospitals and surgical centers. As these medical centers discover the safety, low cost, improved environmental impact and efficiency of the Streamway System, we anticipate a corresponding conversion of these demonstrations into purchase orders, and we are preparing to meet the demand. The additional slide to our investor presentation provides an overview of the opportunities that are now in our sales pipeline."
About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's Streamway System fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).
BioDrain's Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's Streamway System, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.
Forward-looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and related 8-K filings.
OUTLOOK ANALYSIS FOLLOWS
Account # of Potential Rank System Annual Potential Potential
Name systems Additional Amount Consumable Add'l Add'l
for OR's first Revenue, System Annual
first order first Amount Consum-
order order same able
hospital Revenue
same
hospital
Northern
Midwest
Hospital 1 12 1 1 24,000 168,000 144,000
Northern
Midwest
Hospital -
Birthing 1 0 1 12,565 15,000 - -
Midwest
Health
Center 2 0 1 27,000 25,000 - -
Northern
Midwest
Hospital -
Imaging 1 0 1 12,565 10,000 - -
East Coast
Health
System 5 0 1 89,750 60,000 - -
Minnesota
Surgery
Center 1 3 1 1 15,000 42,000 36,000
California
Children's
Hospital 3 13 1 45,000 30,000 182,000 156,000
South
Florida
Surgery
Center 15 0 2 210,000 180,000 - -
East Coast
Medical
Center 4 18 2 48,000 40,000 252,000 216,000
South
Central
Medical
Center 1 6 2 14,000 12,000 84,000 72,000
Midwest
Medical
Center 5 0 2 54,000 50,000 - -
Northern
Midwest
Medical
Center 1 7 2 1 18,000 98,000 84,000
Northern
Midwest
Medical
Center 4 0 2 45,000 40,000 - -
Northern
Midwest
Medical
Center 1 0 2 1 10,000 - -
California
Children's
Hospital 2 0 2 30,000 20,000 - -
Northern
Midwest
Medical
Center 2 8 2 20,000 25,000 112,000 96,000
Southern
California
Surgery
Center 2 0 2 34,700 32,000 - -
East Coast
Hospital 2 12 2 28,500 16,000 168,000 144,000
Northern
Midwest
Surgery
Center 2 3 2 30,000 20,000 42,000 36,000
South
Florida
Surgery
Center 7 0 2 72,000 150,000 - -
Midwest
Hospital 20 50 3 300,000 250,000 700,000 600,000
Northern
Midwest
Hospital -
Imaging 1 15 3 1 10,000 210,000 180,000
Northern
Midwest
Hospital 33 10 3 330,000 396,000 140,000 120,000
Northern
Midwest
Hospital 1 15 3 14,000 12,000 210,000 180,000
Midwest
Endoscopy
Center 5 0 3 75,000 50,000 - -
122 172 1,492,085 1,510,000 2,408,000 2,064,000
Total Identified + Potential 294
Units
Total Identified Units + , for first order $ 3,002,085
Consumables Revenues
Total Potential Units + , same hospital $ 4,472,000
Consumables Revenues
KEY:
1 = Purchase Order, or verbal commitment received
for purchase.
2 = High level of interest expressed, working through demo / purchasing
process.
3 = initial discussions with preliminary interest
expressed.
NOTE:
The $1 accounts would either be reference accounts or lead ins to additional
significant purchases, once the account is familiar with the System.
Rep Groups Additional States Covered
Pacific West Medical 7
Crown Medical 6
SAE 6
Investor Relations Contact:
Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: Email Contact
Digg this
Bookmark with del.icio.us
Add to Newsvine